Assessment of Cardiovascular Safety of Anti-Osteoporosis Drugs

The incidence of osteoporosis and cardiovascular disease increases with age, and there are potentially shared mechanistic associations between the two conditions. It is therefore highly relevant to understand the cardiovascular implications of osteoporosis medications. These are presented in this na...

Descripción completa

Detalles Bibliográficos
Autores principales: Fuggle, N. R., Cooper, C., Harvey, N. C., Al-Daghri, N., Brandi, M.-L., Bruyere, O., Cano, A., Dennison, E. M., Diez-Perez, A., Kaufman, J.-M., Palacios, S., Prieto-Alhambra, D., Rozenberg, S., Thomas, T., Tremollieres, F., Rizzoli, R., Kanis, J. A., Reginster, J. Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536167/
https://www.ncbi.nlm.nih.gov/pubmed/32725307
http://dx.doi.org/10.1007/s40265-020-01364-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536167/
https://www.ncbi.nlm.nih.gov/pubmed/32725307
http://dx.doi.org/10.1007/s40265-020-01364-2

Ejemplares similares